Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$1.82M Sell
39,643
-1,048
-3% -$50.9K 0.5% 65
2017
Q4
$2.06M Buy
40,691
+1,654
+4% +$87.1K 0.55% 60
2017
Q3
$2.03M Sell
39,037
-3,770
-9% -$184K 0.56% 57
2017
Q2
$2.1M Buy
42,807
+2,242
+6% +$104K 0.59% 55
2017
Q1
$1.91M Buy
40,565
+4,685
+13% +$223K 0.54% 58
2016
Q4
$1.72M Sell
35,880
-12,364
-26% -$567K 0.5% 61
2016
Q3
$1.91M Buy
48,244
+1,622
+3% +$61K 0.58% 53
2016
Q2
$1.66M Buy
46,622
+5,870
+14% +$229K 0.52% 59
2016
Q1
$1.6M Sell
40,752
-281
-0.7% -$10.5K 0.51% 60
2015
Q4
$1.76M Buy
+41,033
New +$1.8M 0.58% 53

Other funds holding MET

Argent Trust's MET Position: Q1 2018 in Review

Argent Trust reduced its MetLife (MET) stake by 2.6% in Q1 2018, selling an estimated $50.9K and leaving 39,643 shares worth $1.82M. The position accounts for 0.5% of the portfolio, ranked #65.

Argent Trust first reported a position in MET in Q4 2015 and has held it in 10 quarters since. The position peaked at $2.1M in Q2 2017. 1,026 funds tracked by Wall St. Rank hold MET as of Q1 2018.

  • Argent Trust held 39,643 shares of MetLife worth $1.82M as of Q1 2018.
  • Argent Trust sold 1,048 MetLife shares in Q1 2018, an estimated $50.9K.
  • MetLife made up 0.5% of Argent Trust's portfolio in Q1 2018, its #65 holding.
  • Argent Trust first reported a position in MetLife in Q4 2015 and has held it in 10 quarters since.
  • Argent Trust's MetLife position peaked at $2.1M in Q2 2017.
  • 1,026 funds tracked by Wall St. Rank held MetLife as of Q1 2018.

Based on Argent Trust's 13F filing for Q1 2018, filed 11 May 2018.